Pathware: 20% of biopsies fail to make a diagnosis. Each repeated procedure costs hospitals $3,000 per occurrence that is unreimbursed. Pathware has developed a biopsy quality assessment tool to verify the sample during the procedure to remove this risk while generating additional revenue for the hospital through established billing codes.
